Be the first to like this
The SVB M&A Healthcare Report 2013 examines the merger and acquisition behavior of private, venture capital-backed biotech and medical device companies.
Based on an analysis of private merger or acquisition transactions of US-based, venture capital-backed companies between 2005 and 2012, Silicon Valley Bank found continued growth in the number of “Big Exits” among biotech, healthcare services and medical device companies. Big Exits were defined as acquisitions where the upfront payment totaled in excess of $50 million for device and service companies and $75 million for biotech companies.
- 38 Big Exits in 2012 -- 8 year high
- Estimated $16 billion in payouts to investors in private Big Exit M&A in last three years
- 44% of achievable milestones hit in structured biotech and device deals